CVE-2025-46814

FastAPI Guard Remote Header Injection via X-Forwarded-For Manipulation

Description

FastAPI Guard is a security library for FastAPI that provides middleware to control IPs, log requests, and detect penetration attempts. An HTTP header injection vulnerability has been identified in versions prior to 2.0.0. By manipulating the X-Forwarded-For header, an attacker can potentially inject arbitrary IP addresses into the request. This vulnerability can allow attackers to bypass IP-based access controls, mislead logging systems, and impersonate trusted clients. It is especially impactful when the application relies on the X-Forwarded-For header for IP-based authorization or authentication. Users should upgrade to FastAPI Guard version 2.0.0 to receive a fix.

Category

3.4
CVSS
Severity: Low
CVSS 3.1 •
EPSS 0.06%
Affected: rennf93 fastapi-guard
Published at:
Updated at:

References

Frequently Asked Questions

What is the severity of CVE-2025-46814?
CVE-2025-46814 has been scored as a low severity vulnerability.
How to fix CVE-2025-46814?
To fix CVE-2025-46814, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2025-46814 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2025-46814 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2025-46814?
CVE-2025-46814 affects rennf93 fastapi-guard.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.